epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Daliresp
    roflumilast
  • remove Sovuna
    hydroxychloroquine sulfate
  • remove Tyzavan
    vancomycin

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Sovuna (hydroxychloroquine sulfate) + Tyzavan (vancomycin)

Monitor/Modify Tx


hydroxychloroquine + vancomycin

VANCOMYCIN IV: monitor CBC, especially w/ long-term vancomycin; VANCOMYCIN PO use OK: combo may incr. risk of myelosuppression (additive effects)

Additional Considerations

Smiley face Smiley face hydroxychloroquine in Sovuna

monitor ECG in combo with other drugs that prolong QT interval after hydroxychloroquine D/C due to long half-life (32-50 days); combo may incr. risk of QT prolongation, cardiac arrhythmias

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information